US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Biomarin Pharmaceutical

65.41

+0.99501.54%

Volume:573.05K

Turnover:37.19M

Market Cap:12.64B

PE:172.58

High:65.47

Open:64.41

Low:63.57

Close:64.41

52wk High:70.98

52wk Low:49.26

Shares:193.27M

Float Shares:192.12M

Volume Ratio:0.49

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3790

EPS(LYR):1.80

ROE:1.18%

ROA:3.26%

PB:2.00

PE(LYR):36.34

Loading ...

Overview Company News Filings

BioMarin’s IMPALA Study Aims to Boost Palynziq Value With Better Tolerability

BioMarin Pharmaceutical Presents 3-Year Voxzogo Data, Early BMN 333 Results for Growth Disorder Treatments

MT Newswires Live

BioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia

BioMarin says VOXZOGO lifts height SDS 0.72 over three years in hypochondroplasia study at ENDO 2026

Is VOXZOGO’s Hypochondroplasia Data and Amicus Deal Reshaping the Investment Case for BioMarin (BMRN)?

Simply Wall St.

BioMarin shareholders approved 7,650,000-share increase to 2017 equity plan at annual meeting

A Look At BioMarin Pharmaceutical (BMRN) Valuation After Recent Share Price Strength

Simply Wall St.

BioMarin Pharmaceutical (BMRN) Receives a Buy from Guggenheim

Centene, Deckers and 14 Other 'Dividend Hopefuls' -- Barrons.com

Capricor names Michael Maurer chief commercial officer

BioMarin Pharmaceutical (BMRN) Receives a Hold from Stifel Nicolaus

Wall Street Analysts Are Bullish on Top Healthcare Picks

BioMarin Pharmaceutical Is Maintained at Buy by Canaccord Genuity

BioMarin price target lowered to $111 from $116 at Canaccord

BioMarin's drug shows significant growth gains in children in late-stage trial

BioMarin Says Phase 3 Study of Voxzogo Shows Patient Improvements

BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial

BioMarin plans FDA filing in Q3 2026 for Voxzogo in hypochondroplasia

Biomarin Pharmaceutical Inc: Safety Findings Consistent With Established Profile in Achondroplasia

THOMSON REUTERS

Biomarin Pharmaceutical Inc - No New Safety Signals Identified in Phase 3 Study

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/BMRN/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","market":"US","secType":"STK","nameCN":"Biomarin Pharmaceutical","latestPrice":65.405,"timestamp":1789061159087,"preClose":64.41,"halted":0,"volume":573048,"delay":0,"changeRate":0.01544791181493564,"floatShares":192116189,"shares":193270028,"eps":0.378983,"marketStatus":"Trading","change":0.995,"latestTime":"09-10 13:25:59 EDT","open":64.405,"high":65.47,"low":63.5742,"amount":37192585.91832,"amplitude":0.029433,"askPrice":65.44,"askSize":24,"bidPrice":65.36,"bidSize":1,"shortable":3,"etf":0,"ttmEps":0.378983,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":932702400000,"exchange":"NASDAQ","adjPreClose":64.41,"preHourTrading":{"tag":"盘前","latestPrice":64.31,"preClose":64.41,"latestTime":"09:29 EDT","volume":399,"amount":25607.403045,"timestamp":1789046999999,"change":-0.1,"changeRate":-0.001553,"amplitude":0.008024},"postHourTrading":{"tag":"盘后","latestPrice":64.41,"preClose":64.41,"latestTime":"19:30 EDT","volume":389880,"amount":25112179.84,"timestamp":1788996609520,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.487831,"impliedVol":0.4056,"impliedVolPercentile":0.3586},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMRN\",,,,,undefined,":{"symbol":"BMRN","floatShares":192116189,"roa":"3.26%","roe":"1.18%","lyrEps":1.8,"volumeRatio":0.487831,"shares":193270028,"dividePrice":0,"high":65.47,"amplitude":0.029433,"preClose":64.41,"low":63.5742,"week52Low":49.2592,"pbRate":"2.00","psRate":"3.71","week52High":70.98,"institutionHeld":0.92,"latestPrice":65.405,"committee":-0.92,"eps":0.378983,"divideRate":0,"volume":573048,"delay":0,"ttmEps":0.378983,"open":64.405,"prevYearClose":59.43,"prevWeekClose":66.53,"prevMonthClose":65.23,"prevQuarterClose":57.22,"fiveDayClose":66.97,"twentyDayClose":70.24,"sixtyDayClose":55.65},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMRN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"BMRN","fiscalQuarterEnding":"2026/06","expectedEps":0.79,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":0.9},{"market":"US","date":"2026-05-04","symbol":"BMRN","fiscalQuarterEnding":"2026/03","expectedEps":0.78,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1777867200000,"reportTimeType":"post","actualEps":0.58},{"market":"US","date":"2026-02-23","symbol":"BMRN","fiscalQuarterEnding":"2025/12","expectedEps":0.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771822800000,"reportTimeType":"post","actualEps":0.28},{"market":"US","date":"2025-10-27","symbol":"BMRN","fiscalQuarterEnding":"2025/09","expectedEps":0.82,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1761537600000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2025-08-04","symbol":"BMRN","fiscalQuarterEnding":"2025/06","expectedEps":0.8,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754280000000,"reportTimeType":"post","actualEps":1.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMRN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMRN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2759,"buy":0.4828,"hold":0.2414,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4828,"analysts":29,"updateTime":1787112000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMRN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMRN","date":"2026-09-08","current":169.954853,"percent":0.709677,"low":-246.955768,"twenty":21.715025,"median":77.170006,"eighty":243.147614,"high":1069.125802,"avg":161.970181,"sd":251.428912,"marketCap":12878462186},"quantilePoints":[{"date":"2021-09-10","current":17.077843,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14297808844},{"date":"2021-09-17","current":17.029662,"twenty":-144.931156,"median":-82.965863,"eighty":17.275493,"marketCap":14257471348},{"date":"2021-09-24","current":17.213624,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14411487243},{"date":"2021-10-01","current":16.89826,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14147459995},{"date":"2021-10-08","current":17.044992,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":14270306006},{"date":"2021-10-15","current":16.620127,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13914602631},{"date":"2021-10-22","current":16.14927,"twenty":-144.931156,"median":-82.965863,"eighty":17.308169,"marketCap":13520395283},{"date":"2021-10-29","current":913.742979,"twenty":-144.931156,"median":-82.965863,"eighty":17.356508,"marketCap":14544047003},{"date":"2021-11-05","current":967.9689,"twenty":-144.931156,"median":-82.965863,"eighty":17.405709,"marketCap":15407160981},{"date":"2021-11-12","current":942.70851,"twenty":-144.931156,"median":-82.965863,"eighty":17.560148,"marketCap":15005091360},{"date":"2021-11-19","current":1055.053805,"twenty":-144.931156,"median":-82.965863,"eighty":17.678992,"marketCap":16793291407},{"date":"2021-11-26","current":1010.184893,"twenty":-144.931156,"median":-82.965863,"eighty":17.719077,"marketCap":16079112949},{"date":"2021-12-03","current":956.780508,"twenty":-144.931156,"median":-82.965863,"eighty":17.763785,"marketCap":15229075350},{"date":"2021-12-10","current":979.157292,"twenty":-144.931156,"median":-82.965863,"eighty":17.780334,"marketCap":15585246612},{"date":"2021-12-17","current":997.497027,"twenty":-144.931156,"median":-82.965863,"eighty":17.854801,"marketCap":15877160172},{"date":"2021-12-23","current":1051.478133,"twenty":-144.931156,"median":-82.965863,"eighty":17.921454,"marketCap":16736377443},{"date":"2021-12-31","current":1019.0664,"twenty":-144.931156,"median":-82.965863,"eighty":18.068316,"marketCap":16220479893},{"date":"2022-01-07","current":971.77526,"twenty":-144.868574,"median":-82.756306,"eighty":18.102568,"marketCap":15467746814},{"date":"2022-01-14","current":1040.635774,"twenty":-144.868574,"median":-82.756306,"eighty":18.18902,"marketCap":16563799615},{"date":"2022-01-21","current":976.38903,"twenty":-144.868574,"median":-82.756306,"eighty":18.272526,"marketCap":15541184188},{"date":"2022-01-28","current":993.806011,"twenty":-144.868574,"median":-82.756306,"eighty":18.302,"marketCap":15818410273},{"date":"2022-02-04","current":1022.296039,"twenty":-144.868574,"median":-82.756306,"eighty":18.385092,"marketCap":16271886055},{"date":"2022-02-11","current":1048.594527,"twenty":-144.868574,"median":-82.756306,"eighty":18.50696,"marketCap":16690479084},{"date":"2022-02-18","current":978.811259,"twenty":-144.868574,"median":-82.756306,"eighty":18.612353,"marketCap":15579738809},{"date":"2022-02-25","current":-223.863547,"twenty":-146.720429,"median":-83.128851,"eighty":18.645295,"marketCap":14345176092},{"date":"2022-03-04","current":-219.184373,"twenty":-148.717362,"median":-83.543308,"eighty":18.645295,"marketCap":14045334603},{"date":"2022-03-11","current":-218.207922,"twenty":-159.853208,"median":-83.818061,"eighty":18.645295,"marketCap":13982763668},{"date":"2022-03-18","current":-234.549105,"twenty":-161.293219,"median":-83.967078,"eighty":18.645295,"marketCap":15029906670},{"date":"2022-03-25","current":-226.938537,"twenty":-162.185225,"median":-84.288399,"eighty":18.645295,"marketCap":14542221441},{"date":"2022-04-01","current":-227.656515,"twenty":-163.361234,"median":-84.633004,"eighty":18.645295,"marketCap":14588229481},{"date":"2022-04-08","current":-246.955768,"twenty":-164.641244,"median":-84.986921,"eighty":18.645295,"marketCap":15824925610},{"date":"2022-04-14","current":-238.225154,"twenty":-165.041247,"median":-85.857746,"eighty":18.645295,"marketCap":15265467837},{"date":"2022-04-22","current":-232.276832,"twenty":-165.973254,"median":-88.12096,"eighty":18.645295,"marketCap":14884299384},{"date":"2022-04-29","current":382.277246,"twenty":-166.445258,"median":-90.308931,"eighty":18.664196,"marketCap":15041462794},{"date":"2022-05-06","current":372.455987,"twenty":-166.445258,"median":-89.349626,"eighty":18.760072,"marketCap":14655025704},{"date":"2022-05-13","current":365.458317,"twenty":-166.445258,"median":-89.349626,"eighty":18.859197,"marketCap":14379688400},{"date":"2022-05-20","current":374.814577,"twenty":-166.445258,"median":-89.349626,"eighty":18.955948,"marketCap":14747829142},{"date":"2022-05-27","current":380.691624,"twenty":-166.445258,"median":-89.349626,"eighty":19.066512,"marketCap":14979073327},{"date":"2022-06-03","current":364.329924,"twenty":-166.445258,"median":-89.349626,"eighty":19.178673,"marketCap":14335289516},{"date":"2022-06-10","current":352.998976,"twenty":-166.445258,"median":-89.349626,"eighty":19.261875,"marketCap":13889450727},{"date":"2022-06-17","current":357.700614,"twenty":-166.445258,"median":-89.349626,"eighty":19.519294,"marketCap":14074446075},{"date":"2022-06-24","current":408.337255,"twenty":-166.509258,"median":-86.272203,"eighty":107.93637,"marketCap":16066845973},{"date":"2022-07-01","current":399.545192,"twenty":-166.509258,"median":-84.809963,"eighty":110.39574,"marketCap":15720904673},{"date":"2022-07-08","current":418.539809,"twenty":-166.509258,"median":-84.754081,"eighty":111.051374,"marketCap":16468285878},{"date":"2022-07-15","current":409.418632,"twenty":-166.509258,"median":-83.152135,"eighty":111.935442,"marketCap":16109394903},{"date":"2022-07-22","current":400.720602,"twenty":-166.509258,"median":-83.077626,"eighty":112.591077,"marketCap":15767153510},{"date":"2022-07-29","current":404.575945,"twenty":-166.509258,"median":-81.708522,"eighty":113.113211,"marketCap":15918849695},{"date":"2022-08-05","current":327.838991,"twenty":-166.509258,"median":-34.536978,"eighty":114.110012,"marketCap":17726254245},{"date":"2022-08-12","current":325.272938,"twenty":-166.509258,"median":-34.536978,"eighty":114.976279,"marketCap":17587507734},{"date":"2022-08-19","current":318.464838,"twenty":-166.509258,"median":-34.536978,"eighty":115.685314,"marketCap":17219393812},{"date":"2022-08-26","current":312.187472,"twenty":-166.509258,"median":-34.536978,"eighty":116.907582,"marketCap":16879976635},{"date":"2022-09-02","current":307.488024,"twenty":-166.509258,"median":-34.536978,"eighty":117.883617,"marketCap":16625877437},{"date":"2022-09-09","current":318.773561,"twenty":-166.509258,"median":-34.536978,"eighty":141.162306,"marketCap":17236086460},{"date":"2022-09-16","current":302.58276,"twenty":-166.509258,"median":-34.536978,"eighty":148.167383,"marketCap":16360649808},{"date":"2022-09-23","current":291.022801,"twenty":-166.509258,"median":-34.536978,"eighty":150.289725,"marketCap":15735602876},{"date":"2022-09-30","current":290.782684,"twenty":-166.509258,"median":-34.536978,"eighty":152.726136,"marketCap":15722619705},{"date":"2022-10-07","current":302.376944,"twenty":-166.509258,"median":-34.536978,"eighty":167.017841,"marketCap":16349521376},{"date":"2022-10-14","current":299.289715,"twenty":-166.509258,"median":-34.536978,"eighty":168.933976,"marketCap":16182594895},{"date":"2022-10-21","current":308.757218,"twenty":-166.509258,"median":-34.536978,"eighty":170.628042,"marketCap":16694502768},{"date":"2022-10-28","current":192.178834,"twenty":-166.509258,"median":-34.536978,"eighty":175.146289,"marketCap":16126110354},{"date":"2022-11-04","current":182.699459,"twenty":-166.509258,"median":-34.536978,"eighty":176.471621,"marketCap":15330676998},{"date":"2022-11-11","current":181.968573,"twenty":-166.509258,"median":-34.536978,"eighty":178.346579,"marketCap":15269346856},{"date":"2022-11-18","current":195.589638,"twenty":-166.509258,"median":-34.536978,"eighty":182.260927,"marketCap":16412317683},{"date":"2022-11-25","current":214.659129,"twenty":-166.509258,"median":-34.536978,"eighty":187.341695,"marketCap":18012476841},{"date":"2022-12-02","current":233.795065,"twenty":-166.509258,"median":-34.536978,"eighty":190.997361,"marketCap":19618211467},{"date":"2022-12-09","current":226.641237,"twenty":-166.509258,"median":-34.536978,"eighty":192.536436,"marketCap":19017919471},{"date":"2022-12-16","current":240.594523,"twenty":-166.509258,"median":-34.14536,"eighty":193.90401,"marketCap":20188767636},{"date":"2022-12-23","current":231.093,"twenty":-166.509258,"median":-33.835795,"eighty":195.798534,"marketCap":19391475791},{"date":"2022-12-30","current":229.210413,"twenty":-166.509258,"median":15.910621,"eighty":196.943179,"marketCap":19233504213},{"date":"2023-01-06","current":240.771708,"twenty":-166.509258,"median":15.99843,"eighty":199.747589,"marketCap":20203635549},{"date":"2023-01-13","current":249.653085,"twenty":-166.509258,"median":16.07919,"eighty":201.466427,"marketCap":20948889698},{"date":"2023-01-20","current":245.289915,"twenty":-166.509258,"median":16.188691,"eighty":202.812136,"marketCap":20582767336},{"date":"2023-01-27","current":259.730459,"twenty":-166.509258,"median":16.239185,"eighty":206.755441,"marketCap":21794502262},{"date":"2023-02-03","current":248.501386,"twenty":-166.509258,"median":16.333756,"eighty":220.240444,"marketCap":20852248263},{"date":"2023-02-10","current":242.432813,"twenty":-166.509258,"median":16.413891,"eighty":226.49506,"marketCap":20343022235},{"date":"2023-02-17","current":239.885785,"twenty":-166.509258,"median":16.442734,"eighty":229.440754,"marketCap":20129295983},{"date":"2023-02-24","current":226.065387,"twenty":-166.509258,"median":16.476957,"eighty":230.229225,"marketCap":18969598754},{"date":"2023-03-03","current":133.346847,"twenty":-166.509258,"median":16.516158,"eighty":230.229225,"marketCap":18876712940},{"date":"2023-03-10","current":119.234744,"twenty":-166.509258,"median":16.567292,"eighty":230.229225,"marketCap":16878989664},{"date":"2023-03-17","current":120.789579,"twenty":-166.509258,"median":16.617476,"eighty":230.229225,"marketCap":17099093629},{"date":"2023-03-24","current":119.564159,"twenty":-166.509258,"median":16.650384,"eighty":230.229225,"marketCap":16925621860},{"date":"2023-03-31","current":128.128926,"twenty":-166.445258,"median":16.685656,"eighty":229.9413,"marketCap":18138058956},{"date":"2023-04-06","current":127.246097,"twenty":-166.445258,"median":16.720301,"eighty":229.9413,"marketCap":18013084670},{"date":"2023-04-14","current":129.578349,"twenty":-166.509258,"median":16.77077,"eighty":230.229225,"marketCap":18343240618},{"date":"2023-04-21","current":127.575511,"twenty":-166.509258,"median":16.817229,"eighty":230.229225,"marketCap":18059716866},{"date":"2023-04-28","current":242.180022,"twenty":-166.509258,"median":16.855933,"eighty":231.407502,"marketCap":17343722249},{"date":"2023-05-05","current":250.17182,"twenty":-166.509258,"median":16.91578,"eighty":235.380867,"marketCap":17916054913},{"date":"2023-05-12","current":250.014562,"twenty":-166.573259,"median":16.941683,"eighty":237.019824,"marketCap":17904792857},{"date":"2023-05-19","current":241.732289,"twenty":-166.637259,"median":16.967171,"eighty":239.8282,"marketCap":17311657880},{"date":"2023-05-26","current":232.558885,"twenty":-166.637259,"median":17.014711,"eighty":240.585664,"marketCap":16654704583},{"date":"2023-05-30","current":231.916747,"twenty":-166.637259,"median":17.029662,"eighty":240.585664,"marketCap":16608717852},{"date":"2023-06-09","current":241.810918,"twenty":-166.73726,"median":17.061278,"eighty":241.008901,"marketCap":17317288908},{"date":"2023-06-16","current":251.194,"twenty":-166.74926,"median":17.112883,"eighty":241.385297,"marketCap":17989258281},{"date":"2023-06-23","current":250.591176,"twenty":-166.76126,"median":17.196104,"eighty":241.856963,"marketCap":17946087064},{"date":"2023-06-30","current":233.08308,"twenty":-166.76126,"median":17.241,"eighty":242.23058,"marketCap":16692244772},{"date":"2023-07-07","current":224.355242,"twenty":-166.76126,"median":17.308262,"eighty":242.23058,"marketCap":16067200635},{"date":"2023-07-14","current":224.643549,"twenty":-166.76126,"median":17.371372,"eighty":242.23058,"marketCap":16087847738},{"date":"2023-07-21","current":229.439928,"twenty":-166.76126,"median":17.48024,"eighty":242.23058,"marketCap":16431340462},{"date":"2023-07-28","current":226.871375,"twenty":-166.76126,"median":17.641098,"eighty":242.23058,"marketCap":16247393539},{"date":"2023-08-04","current":165.119407,"twenty":-166.76126,"median":17.695247,"eighty":242.23058,"marketCap":16510454583},{"date":"2023-08-11","current":171.085084,"twenty":-166.76126,"median":17.746561,"eighty":242.23058,"marketCap":17106968613},{"date":"2023-08-18","current":168.243389,"twenty":-166.76126,"median":17.778035,"eighty":242.23058,"marketCap":16822824706},{"date":"2023-08-25","current":175.281759,"twenty":-166.76126,"median":17.843539,"eighty":242.23058,"marketCap":17526598357},{"date":"2023-09-01","current":171.969585,"twenty":-166.76126,"median":17.901573,"eighty":242.23058,"marketCap":17195410756},{"date":"2023-09-08","current":170.162944,"twenty":-166.76126,"median":18.020515,"eighty":242.23058,"marketCap":17014762974},{"date":"2023-09-15","current":165.006492,"twenty":-166.76126,"median":18.09038,"eighty":242.23058,"marketCap":16499164096},{"date":"2023-09-22","current":162.352988,"twenty":-166.76126,"median":18.138595,"eighty":242.23058,"marketCap":16233837666},{"date":"2023-09-29","current":167.961101,"twenty":-166.76126,"median":18.255988,"eighty":242.23058,"marketCap":16794598490},{"date":"2023-10-06","current":164.272544,"twenty":-166.76126,"median":18.295251,"eighty":242.23058,"marketCap":16425775935},{"date":"2023-10-13","current":162.861106,"twenty":-166.76126,"median":18.372948,"eighty":242.23058,"marketCap":16284644855},{"date":"2023-10-20","current":155.427533,"twenty":-166.76126,"median":18.480739,"eighty":242.23058,"marketCap":15541354502},{"date":"2023-10-27","current":154.260745,"twenty":-166.76126,"median":18.544458,"eighty":242.382255,"marketCap":15424686142},{"date":"2023-11-03","current":102.060294,"twenty":-166.76126,"median":18.649124,"eighty":242.382255,"marketCap":15005006530},{"date":"2023-11-10","current":107.264835,"twenty":-166.76126,"median":18.746862,"eighty":242.382255,"marketCap":15770183276},{"date":"2023-11-17","current":111.736338,"twenty":-166.76126,"median":18.837592,"eighty":242.382255,"marketCap":16427588192},{"date":"2023-11-24","current":112.991947,"twenty":-166.76126,"median":18.922633,"eighty":242.382255,"marketCap":16612189000},{"date":"2023-12-01","current":116.69471,"twenty":-166.76126,"median":18.980092,"eighty":242.382255,"marketCap":17156573014},{"date":"2023-12-08","current":121.64027,"twenty":-166.76126,"median":19.115548,"eighty":242.331697,"marketCap":17883674154},{"date":"2023-12-15","current":125.073975,"twenty":-166.76126,"median":19.224871,"eighty":242.331697,"marketCap":18388500853},{"date":"2023-12-22","current":121.922141,"twenty":-166.76126,"median":19.421383,"eighty":242.331697,"marketCap":17925115152},{"date":"2023-12-29","current":124.446171,"twenty":-166.76126,"median":97.655587,"eighty":242.382255,"marketCap":18296200449},{"date":"2024-01-05","current":125.21491,"twenty":-166.76126,"median":106.724665,"eighty":242.432813,"marketCap":18409221351},{"date":"2024-01-12","current":122.998377,"twenty":-166.76126,"median":107.662485,"eighty":242.432813,"marketCap":18083344416},{"date":"2024-01-19","current":118.552498,"twenty":-166.79726,"median":109.532617,"eighty":242.575773,"marketCap":17429706862},{"date":"2024-01-26","current":116.91252,"twenty":-166.76126,"median":110.397223,"eighty":242.432813,"marketCap":17188595603},{"date":"2024-02-02","current":113.696625,"twenty":-166.76126,"median":111.153724,"eighty":242.432813,"marketCap":16715791494},{"date":"2024-02-09","current":112.940697,"twenty":-166.76126,"median":111.821225,"eighty":242.432813,"marketCap":16604654273},{"date":"2024-02-16","current":113.132882,"twenty":-166.76126,"median":112.099749,"eighty":242.432813,"marketCap":16632909499},{"date":"2024-02-23","current":101.214924,"twenty":-166.70126,"median":112.294622,"eighty":242.432813,"marketCap":16968175915},{"date":"2024-03-01","current":97.103598,"twenty":-165.901253,"median":112.199476,"eighty":242.382255,"marketCap":16278932666},{"date":"2024-03-08","current":96.664673,"twenty":-164.837246,"median":112.199476,"eighty":242.382255,"marketCap":16205349173},{"date":"2024-03-15","current":94.976502,"twenty":-164.11324,"median":112.199476,"eighty":242.382255,"marketCap":15922335740},{"date":"2024-03-22","current":94.661377,"twenty":-162.221226,"median":112.199476,"eighty":242.382255,"marketCap":15869506566},{"date":"2024-03-28","current":99.72589,"twenty":-162.081225,"median":112.199476,"eighty":242.382255,"marketCap":16718546865},{"date":"2024-04-05","current":97.790121,"twenty":-160.981216,"median":112.294622,"eighty":242.432813,"marketCap":16394024795},{"date":"2024-04-12","current":103.533211,"twenty":-131.648601,"median":112.294622,"eighty":242.432813,"marketCap":17356825158},{"date":"2024-04-19","current":101.959724,"twenty":-125.404689,"median":112.294622,"eighty":242.432813,"marketCap":17093037852},{"date":"2024-04-26","current":75.899547,"twenty":-124.450186,"median":112.199476,"eighty":242.382255,"marketCap":15593941332},{"date":"2024-05-03","current":77.447263,"twenty":-123.068927,"median":112.199476,"eighty":242.382255,"marketCap":15911927491},{"date":"2024-05-10","current":75.524945,"twenty":-121.619256,"median":112.199476,"eighty":242.382255,"marketCap":15516977501},{"date":"2024-05-17","current":71.135034,"twenty":-119.850332,"median":112.199476,"eighty":242.382255,"marketCap":14615048436},{"date":"2024-05-24","current":70.146149,"twenty":-118.560287,"median":112.199476,"eighty":242.382255,"marketCap":14411877047},{"date":"2024-05-31","current":69.37907,"twenty":-117.48525,"median":112.199476,"eighty":242.382255,"marketCap":14254276811},{"date":"2024-06-07","current":74.573027,"twenty":-116.644766,"median":112.199476,"eighty":242.382255,"marketCap":15321401304},{"date":"2024-06-14","current":77.179248,"twenty":-111.14579,"median":112.199476,"eighty":242.382255,"marketCap":15856862348},{"date":"2024-06-21","current":77.42878,"twenty":-109.718923,"median":112.294622,"eighty":242.432813,"marketCap":15908129895},{"date":"2024-06-28","current":76.088702,"twenty":-105.956293,"median":112.294622,"eighty":242.432813,"marketCap":15632804180},{"date":"2024-07-05","current":75.275413,"twenty":-104.685795,"median":112.294622,"eighty":242.432813,"marketCap":15465709954},{"date":"2024-07-12","current":78.574777,"twenty":15.974047,"median":112.294622,"eighty":242.432813,"marketCap":16143580851},{"date":"2024-07-19","current":77.715279,"twenty":16.07669,"median":112.294622,"eighty":242.432813,"marketCap":15966992634},{"date":"2024-07-26","current":78.177375,"twenty":16.188691,"median":112.294622,"eighty":242.432813,"marketCap":16061932535},{"date":"2024-08-02","current":77.81694,"twenty":16.239185,"median":112.294622,"eighty":242.432813,"marketCap":15987879412},{"date":"2024-08-09","current":65.768733,"twenty":16.333756,"median":112.294622,"eighty":242.432813,"marketCap":16875533342},{"date":"2024-08-16","current":66.429091,"twenty":16.413891,"median":112.294622,"eighty":242.432813,"marketCap":17044974053},{"date":"2024-08-23","current":66.792659,"twenty":16.442734,"median":112.294622,"eighty":242.432813,"marketCap":17138261636},{"date":"2024-08-30","current":67.67561,"twenty":16.477433,"median":112.294622,"eighty":242.432813,"marketCap":17364817194},{"date":"2024-09-06","current":62.385323,"twenty":16.516158,"median":112.294622,"eighty":242.432813,"marketCap":16007387673},{"date":"2024-09-13","current":62.993743,"twenty":16.567292,"median":112.294622,"eighty":242.432813,"marketCap":16163501587},{"date":"2024-09-20","current":52.450267,"twenty":16.617476,"median":112.294622,"eighty":242.432813,"marketCap":13458161687},{"date":"2024-09-27","current":52.36865,"twenty":16.650384,"median":112.294622,"eighty":242.432813,"marketCap":13437219576},{"date":"2024-10-04","current":51.574736,"twenty":16.689865,"median":112.294622,"eighty":242.432813,"marketCap":13233509957},{"date":"2024-10-11","current":52.197996,"twenty":16.740578,"median":112.294622,"eighty":242.432813,"marketCap":13393431527},{"date":"2024-10-18","current":52.019922,"twenty":16.78674,"median":112.294622,"eighty":242.432813,"marketCap":13347739650},{"date":"2024-10-25","current":51.737971,"twenty":16.823799,"median":112.294622,"eighty":242.432813,"marketCap":13275394178},{"date":"2024-11-01","current":39.383132,"twenty":16.89388,"median":112.294622,"eighty":242.432813,"marketCap":12692828865},{"date":"2024-11-08","current":39.661061,"twenty":16.92235,"median":112.294622,"eighty":242.432813,"marketCap":12782402883},{"date":"2024-11-15","current":37.502676,"twenty":16.946441,"median":112.294622,"eighty":242.432813,"marketCap":12086774874},{"date":"2024-11-22","current":37.9994,"twenty":16.977101,"median":112.294622,"eighty":242.432813,"marketCap":12246864608},{"date":"2024-11-29","current":39.046069,"twenty":17.029662,"median":112.294622,"eighty":242.432813,"marketCap":12584196546},{"date":"2024-12-06","current":39.465919,"twenty":17.060322,"median":112.294622,"eighty":242.432813,"marketCap":12719510487},{"date":"2024-12-13","current":39.034242,"twenty":17.110693,"median":112.294622,"eighty":242.432813,"marketCap":12580384886},{"date":"2024-12-20","current":38.827274,"twenty":17.196104,"median":112.294622,"eighty":242.432813,"marketCap":12513680830},{"date":"2024-12-27","current":39.55462,"twenty":17.220194,"median":112.294622,"eighty":242.432813,"marketCap":12748097940},{"date":"2025-01-03","current":39.519139,"twenty":17.307796,"median":112.294622,"eighty":242.432813,"marketCap":12736662959},{"date":"2025-01-10","current":39.844375,"twenty":17.365255,"median":112.389767,"eighty":242.575773,"marketCap":12841483618},{"date":"2025-01-17","current":36.385046,"twenty":17.450199,"median":112.389767,"eighty":242.575773,"marketCap":11726572974},{"date":"2025-01-24","current":36.503314,"twenty":17.562906,"median":112.389767,"eighty":242.575773,"marketCap":11764689577},{"date":"2025-01-31","current":37.467195,"twenty":17.680666,"median":112.389767,"eighty":242.575773,"marketCap":12075339893},{"date":"2025-02-07","current":37.804258,"twenty":17.732712,"median":112.389767,"eighty":242.575773,"marketCap":12183972212},{"date":"2025-02-14","current":38.34829,"twenty":17.773898,"median":112.389767,"eighty":242.575773,"marketCap":12359308587},{"date":"2025-02-21","current":30.500615,"twenty":17.780334,"median":112.389767,"eighty":242.575773,"marketCap":13019462069},{"date":"2025-02-28","current":31.803699,"twenty":17.85572,"median":112.389767,"eighty":242.575773,"marketCap":13575695020},{"date":"2025-03-07","current":32.281916,"twenty":18.006035,"median":112.415391,"eighty":242.718733,"marketCap":13779826465},{"date":"2025-03-14","current":31.034975,"twenty":18.081882,"median":112.415391,"eighty":242.718733,"marketCap":13247558490},{"date":"2025-03-21","current":31.839453,"twenty":18.118783,"median":112.415391,"eighty":242.718733,"marketCap":13590957184},{"date":"2025-03-28","current":31.92884,"twenty":18.238419,"median":112.415391,"eighty":242.718733,"marketCap":13629112594},{"date":"2025-04-04","current":26.932137,"twenty":18.288668,"median":112.415391,"eighty":242.718733,"marketCap":11496225153},{"date":"2025-04-11","current":25.524756,"twenty":18.312181,"median":112.389767,"eighty":242.575773,"marketCap":10895471939},{"date":"2025-04-17","current":26.580426,"twenty":18.41352,"median":112.389767,"eighty":242.575773,"marketCap":11346094238},{"date":"2025-04-25","current":28.435711,"twenty":18.53764,"median":112.415391,"eighty":242.718733,"marketCap":12138038961},{"date":"2025-05-02","current":22.707063,"twenty":18.58729,"median":112.139927,"eighty":242.718733,"marketCap":11895844499},{"date":"2025-05-09","current":21.546635,"twenty":18.58729,"median":111.745407,"eighty":242.718733,"marketCap":11287915641},{"date":"2025-05-16","current":21.696722,"twenty":18.58729,"median":111.057308,"eighty":242.718733,"marketCap":11366543664},{"date":"2025-05-23","current":21.235479,"twenty":18.58729,"median":110.374974,"eighty":242.718733,"marketCap":11124906326},{"date":"2025-05-30","current":21.433154,"twenty":18.58729,"median":109.878551,"eighty":242.718733,"marketCap":11228465185},{"date":"2025-06-06","current":20.232458,"twenty":18.58729,"median":107.994221,"eighty":242.718733,"marketCap":10599441004},{"date":"2025-06-13","current":20.968251,"twenty":18.58729,"median":106.858165,"eighty":242.718733,"marketCap":10984910091},{"date":"2025-06-20","current":20.221476,"twenty":18.578788,"median":103.589811,"eighty":242.861694,"marketCap":10593687734},{"date":"2025-06-27","current":19.804161,"twenty":18.578788,"median":102.118204,"eighty":242.861694,"marketCap":10375063476},{"date":"2025-07-03","current":21.048785,"twenty":18.578788,"median":101.959724,"eighty":242.861694,"marketCap":11027100737},{"date":"2025-07-11","current":21.531992,"twenty":18.578788,"median":100.329636,"eighty":242.861694,"marketCap":11280244615},{"date":"2025-07-18","current":21.367262,"twenty":18.578788,"median":98.296572,"eighty":242.861694,"marketCap":11193945566},{"date":"2025-07-25","current":21.876094,"twenty":18.578788,"median":97.790121,"eighty":242.861694,"marketCap":11460513740},{"date":"2025-08-01","current":21.176908,"twenty":18.578788,"median":97.373705,"eighty":242.861694,"marketCap":11094222220},{"date":"2025-08-08","current":17.371388,"twenty":18.507812,"median":96.664673,"eighty":242.861694,"marketCap":11417188175},{"date":"2025-08-15","current":16.944845,"twenty":18.385518,"median":95.392918,"eighty":242.861694,"marketCap":11136846858},{"date":"2025-08-22","current":16.965296,"twenty":18.302426,"median":84.240461,"eighty":242.861694,"marketCap":11150287880},{"date":"2025-08-29","current":16.851356,"twenty":18.272864,"median":78.68568,"eighty":242.861694,"marketCap":11075402185},{"date":"2025-09-05","current":16.579654,"twenty":18.18902,"median":78.265173,"eighty":243.004654,"marketCap":10896828606},{"date":"2025-09-12","current":16.334246,"twenty":18.103027,"median":78.177375,"eighty":242.861694,"marketCap":10735536341},{"date":"2025-09-19","current":16.109289,"twenty":18.073255,"median":77.853908,"eighty":242.861694,"marketCap":10587685099},{"date":"2025-09-26","current":15.373065,"twenty":17.971559,"median":77.548924,"eighty":242.861694,"marketCap":10103808304},{"date":"2025-10-03","current":16.234914,"twenty":17.854801,"median":77.170006,"eighty":242.861694,"marketCap":10670251377},{"date":"2025-10-10","current":15.732412,"twenty":17.780334,"median":76.412169,"eighty":242.861694,"marketCap":10339986263},{"date":"2025-10-17","current":15.469475,"twenty":17.763785,"median":75.98704,"eighty":242.861694,"marketCap":10167173122},{"date":"2025-10-24","current":15.936919,"twenty":17.724471,"median":75.626606,"eighty":242.861694,"marketCap":10474396484},{"date":"2025-10-31","current":19.162817,"twenty":17.719077,"median":74.776349,"eighty":242.861694,"marketCap":9972655597},{"date":"2025-11-07","current":19.136976,"twenty":17.728872,"median":74.573027,"eighty":242.861694,"marketCap":9959207592},{"date":"2025-11-14","current":20.015564,"twenty":17.770221,"median":74.573027,"eighty":242.861694,"marketCap":10416439731},{"date":"2025-11-21","current":19.373235,"twenty":17.797802,"median":74.573027,"eighty":242.861694,"marketCap":10082160773},{"date":"2025-11-28","current":20.646818,"twenty":17.854801,"median":74.573027,"eighty":242.861694,"marketCap":10744955259},{"date":"2025-12-05","current":19.867902,"twenty":17.971559,"median":74.573027,"eighty":242.861694,"marketCap":10339593994},{"date":"2025-12-12","current":19.561504,"twenty":18.073255,"median":74.573027,"eighty":242.861694,"marketCap":10180139088},{"date":"2025-12-19","current":19.177583,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":9980340170},{"date":"2025-12-26","current":22.208342,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11557598935},{"date":"2026-01-02","current":21.93886,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11417355463},{"date":"2026-01-09","current":22.278482,"twenty":18.080963,"median":74.573027,"eighty":242.861694,"marketCap":11594100660},{"date":"2026-01-16","current":20.329345,"twenty":18.110842,"median":74.573027,"eighty":242.861694,"marketCap":10579736924},{"date":"2026-01-23","current":21.108262,"twenty":18.110842,"median":74.573027,"eighty":242.861694,"marketCap":10985098189},{"date":"2026-01-30","current":21.038122,"twenty":18.193189,"median":74.573027,"eighty":242.861694,"marketCap":10948596464},{"date":"2026-02-06","current":21.097187,"twenty":18.283472,"median":74.573027,"eighty":242.861694,"marketCap":10979334759},{"date":"2026-02-13","current":22.127128,"twenty":18.296023,"median":74.573027,"eighty":242.861694,"marketCap":11515333779},{"date":"2026-02-20","current":23.411787,"twenty":18.447486,"median":74.573027,"eighty":242.861694,"marketCap":12183891696},{"date":"2026-02-27","current":33.681355,"twenty":18.682221,"median":74.573027,"eighty":242.861694,"marketCap":11751458561},{"date":"2026-03-06","current":33.387769,"twenty":18.886778,"median":74.573027,"eighty":242.861694,"marketCap":11649025854},{"date":"2026-03-13","current":32.560929,"twenty":19.024071,"median":74.573027,"eighty":242.861694,"marketCap":11360540816},{"date":"2026-03-20","current":30.333976,"twenty":19.128116,"median":74.573027,"eighty":242.861694,"marketCap":10583554445},{"date":"2026-03-27","current":30.620613,"twenty":19.179593,"median":74.573027,"eighty":242.861694,"marketCap":10683562592},{"date":"2026-04-02","current":31.552185,"twenty":19.246563,"median":74.573027,"eighty":242.861694,"marketCap":11008589069},{"date":"2026-04-10","current":31.034033,"twenty":19.403778,"median":74.573027,"eighty":242.861694,"marketCap":10827805111},{"date":"2026-04-17","current":29.821335,"twenty":19.489367,"median":74.573027,"eighty":242.861694,"marketCap":10404693721},{"date":"2026-04-24","current":29.755188,"twenty":19.677418,"median":74.573027,"eighty":242.861694,"marketCap":10381614918},{"date":"2026-05-01","current":29.862876,"twenty":19.799768,"median":74.573027,"eighty":242.861694,"marketCap":10419187209},{"date":"2026-05-08","current":38.921248,"twenty":19.878238,"median":74.573027,"eighty":242.861694,"marketCap":10459773915},{"date":"2026-05-15","current":38.288382,"twenty":20.070937,"median":74.573027,"eighty":242.861694,"marketCap":10289696290},{"date":"2026-05-22","current":38.909765,"twenty":20.166917,"median":74.573027,"eighty":242.861694,"marketCap":10456688095},{"date":"2026-05-29","current":37.931627,"twenty":20.241499,"median":74.605374,"eighty":243.004654,"marketCap":10193821260},{"date":"2026-06-05","current":40.614315,"twenty":20.395055,"median":74.573027,"eighty":242.861694,"marketCap":10914772213},{"date":"2026-06-12","current":39.945441,"twenty":20.583149,"median":74.573027,"eighty":242.861694,"marketCap":10735017686},{"date":"2026-06-18","current":39.571447,"twenty":20.703188,"median":74.573027,"eighty":242.861694,"marketCap":10634509778},{"date":"2026-06-26","current":41.247228,"twenty":20.787453,"median":74.605374,"eighty":243.004654,"marketCap":11084862519},{"date":"2026-07-02","current":41.585261,"twenty":20.891982,"median":74.605374,"eighty":243.004654,"marketCap":11175706205},{"date":"2026-07-10","current":43.131583,"twenty":20.968983,"median":74.605374,"eighty":243.004654,"marketCap":11591267746},{"date":"2026-07-17","current":43.153159,"twenty":21.042928,"median":74.605374,"eighty":243.004654,"marketCap":11597066280},{"date":"2026-07-24","current":42.340441,"twenty":21.121991,"median":74.605374,"eighty":243.004654,"marketCap":11378654865},{"date":"2026-07-31","current":43.570306,"twenty":21.257443,"median":74.637721,"eighty":243.147614,"marketCap":11709171254},{"date":"2026-08-07","current":162.792051,"twenty":21.272085,"median":74.720898,"eighty":243.147614,"marketCap":11879261559},{"date":"2026-08-14","current":181.790409,"twenty":21.316013,"median":75.524945,"eighty":243.147614,"marketCap":13265609704},{"date":"2026-08-21","current":179.535603,"twenty":21.392511,"median":75.903863,"eighty":243.147614,"marketCap":13101072009},{"date":"2026-08-28","current":173.195619,"twenty":21.528331,"median":76.319749,"eighty":243.147614,"marketCap":12638430725},{"date":"2026-09-04","current":176.219712,"twenty":21.696722,"median":77.022135,"eighty":243.147614,"marketCap":12859104810},{"date":"2026-09-08","current":176.484983,"twenty":21.715025,"median":77.170006,"eighty":243.147614,"marketCap":12878462186}],"updateTime":1789021058135},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMRN\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2644283827","title":"BioMarin’s IMPALA Study Aims to Boost Palynziq Value With Better Tolerability","url":"https://stock-news.laohu8.com/highlight/detail?id=2644283827","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644283827?lang=en_us&edition=fundamental","pubTime":"2026-06-18 00:32","pubTimestamp":1781713932,"startTime":"0","endTime":"0","summary":"Biomarin Pharmaceutical Inc. ($BMRN) announced an update on their ongoing clinical study. BioMarin (BMRN) has launched IMPALA, a Phase 4 study titl...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomarins-impala-study-aims-to-boost-palynziq-value-with-better-tolerability?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomarins-impala-study-aims-to-boost-palynziq-value-with-better-tolerability?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BMRN","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B7SZLL34.SGD","BK4566","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643234768","title":"BioMarin Pharmaceutical Presents 3-Year Voxzogo Data, Early BMN 333 Results for Growth Disorder Treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2643234768","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643234768?lang=en_us&edition=fundamental","pubTime":"2026-06-16 22:04","pubTimestamp":1781618646,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical  said Tuesday it presented new clinical data for its Voxzogo and BMN 333 treatments targeting hypochondroplasia and achondroplasia, both of which are growth-related bone conditions.An investigator-led Phase 2 extension study showed that Voxzogo led to sustained growth improvements in children with hypochondroplasia, the company said.The company intends to submit a supplemental New Drug Application to the US Food and Drug Administration during Q3 based on a separate Phase 3 study, it said.Initial Phase 1 testing of BMN 333 in healthy adults demonstrated prolonged drug exposure supporting a weekly dosing schedule for achondroplasia, BioMarin Pharmaceutical said.Patient enrollment for a Phase 2/3 study of the weekly drug began in April, with a data update from the dose-finding segment expected in 2027, the company added.Price: 55.13, Change: -0.52, Percent Change: -0.93","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B7SZLL34.SGD","IE0002270589.USD","BK4566","IE00B19Z3B42.SGD","BMRN.AU","BMRN","BMN","BK7095","BK4139","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643504987","title":"BioMarin’s Voxzogo and BMN 333 show impact in hypochondroplasia, achondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2643504987","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643504987?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:17","pubTimestamp":1781615869,"startTime":"0","endTime":"0","summary":"BioMarin (BMRN) Pharmaceutical announced new data from studies of Voxzogo – vosoritide – in children with hypochondroplasia and the investigational...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarins-voxzogo-and-bmn-333-show-impact-in-hypochondroplasia-achondroplasia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarins-voxzogo-and-bmn-333-show-impact-in-hypochondroplasia-achondroplasia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B7SZLL34.SGD","BK4139","BK4566","IE0002270589.USD","IE00B19Z3B42.SGD","BMN","IE00B19Z3581.USD","BMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643848750","title":"BioMarin says VOXZOGO lifts height SDS 0.72 over three years in hypochondroplasia study at ENDO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2643848750","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643848750?lang=en_us&edition=fundamental","pubTime":"2026-06-16 21:05","pubTimestamp":1781615153,"startTime":"0","endTime":"0","summary":"BioMarin highlighted new VOXZOGO data in hypochondroplasia, presented at ENDO 2026, showing sustained growth benefits over three years with a favorable safety profile.The update supports plans to file a U.S. supplemental NDA for VOXZOGO in hypochondroplasia in Q3 2026, following positive Phase 3 topline results.Phase 1 results for investigational BMN 333, also presented at ENDO 2026, supported the potential for weekly dosing in achondroplasia with tolerable safety.Enrollment has started in a registration-enabling Phase 2/3 study for BMN 333; a dose-finding update is expected in 2027.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDL3Q38P8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BK4566","IE00B7SZLL34.SGD","BK4139","BMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642494525","title":"Is VOXZOGO’s Hypochondroplasia Data and Amicus Deal Reshaping the Investment Case for BioMarin (BMRN)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2642494525","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642494525?lang=en_us&edition=fundamental","pubTime":"2026-06-10 01:28","pubTimestamp":1781026084,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical recently reported positive Phase 3 results for VOXZOGO in children with hypochondroplasia and advanced multiple regulatory filings and approvals, while integrating Amicus Therapeutics’ rare-disease drugs GALAFOLD and POMBILITI + OPFOLDA into its portfolio.\nThis combination of pipeline progress and portfolio expansion underscores how BioMarin is deepening its focus on genetically driven rare skeletal and metabolic disorders.\nWe’ll now examine how VOXZOGO’s progress in...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/is-voxzogos-hypochondroplasia-data-and-amicus-deal-reshaping","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/is-voxzogos-hypochondroplasia-data-and-amicus-deal-reshaping","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00B7SZLL34.SGD","BK4566","BMRN.AU","IE00B19Z3581.USD","BK4139","IE00B19Z3B42.SGD","BK7095","BMRN","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641162757","title":"BioMarin shareholders approved 7,650,000-share increase to 2017 equity plan at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2641162757","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641162757?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:25","pubTimestamp":1780604726,"startTime":"0","endTime":"0","summary":"BioMarin held its annual shareholder meeting on June 2, 2026.Shareholders adopted an amendment to the 2017 Equity Incentive Plan, adding 7,650,000 shares reserved for issuance; it took effect immediately.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioMarin Pharmaceutical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLbxPh98:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","BK4139","BK4566","IE0002270589.USD","IE00B19Z3581.USD","BMRN","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640688156","title":"A Look At BioMarin Pharmaceutical (BMRN) Valuation After Recent Share Price Strength","url":"https://stock-news.laohu8.com/highlight/detail?id=2640688156","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640688156?lang=en_us&edition=fundamental","pubTime":"2026-06-04 17:39","pubTimestamp":1780565950,"startTime":"0","endTime":"0","summary":"Event context and recent stock move\nBioMarin Pharmaceutical (BMRN) has drawn investor attention after recent trading, with the stock up about 2.5% on the day and 4.4% over the past week, while longer term returns remain weaker.\nSee our latest analysis for BioMarin Pharmaceutical.\nThe latest move sits against a mixed backdrop, with the share price down about 10% over the past three months and year to date, while the 1-year total shareholder return is also slightly negative. This pattern...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/a-look-at-biomarin-pharmaceutical-bmrn-valuation-after-recen-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bmrn/biomarin-pharmaceutical/news/a-look-at-biomarin-pharmaceutical-bmrn-valuation-after-recen-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7095","IE00B19Z3B42.SGD","BMRN","BK4566","IE00B7SZLL34.SGD","BK4139","IE00B19Z3581.USD","IE0002270589.USD","BMRN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640296909","title":"BioMarin Pharmaceutical (BMRN) Receives a Buy from Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2640296909","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640296909?lang=en_us&edition=fundamental","pubTime":"2026-06-03 19:41","pubTimestamp":1780486910,"startTime":"0","endTime":"0","summary":"In a report released today, from Guggenheim maintained a Buy rating on BioMarin Pharmaceutical, with a price target of $86.00. In addition to Gugge...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biomarin-pharmaceutical-bmrn-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biomarin-pharmaceutical-bmrn-receives-a-buy-from-guggenheim-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","IE00B7SZLL34.SGD","IE0002270589.USD","BK4139","IE00B19Z3B42.SGD","IE00B19Z3581.USD","BMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640925449","title":"Centene, Deckers and 14 Other 'Dividend Hopefuls' -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2640925449","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640925449?lang=en_us&edition=fundamental","pubTime":"2026-06-02 13:30","pubTimestamp":1780378200,"startTime":"0","endTime":"0","summary":"Investors love companies that grow dividends over time. But guessing which companies will initiate their first dividend can be a way to get in on the ground floor.More than a dozen large-cap companies could be poised to join the dividend club, based on cash holdings and free-cash flow yield, according to Morgan Stanley. The list includes Centene, Deckers, Airbnb and 13 others, according to a report published last week.S&P 500 companies that initiate and grow dividends have retuned 10.2% a year on average going back to 1973, according to Hartford Funds data, that handily beats both companies that simply pay a dividend  and those that don't pay a dividend .\"Dividends can offer a reliable income stream, signal confidence to the market, and help stabilize portfolios during periods of uncertainty and high valuations,\" wrote the Morgan Stanley team led by strategist Todd Castagno.Deckers, maker of Ugg boots and Hoka sneakers, seems like another potential future payer, given its lin","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2028103732.USD","LU1791710400.SGD","INCY","BK4516","LU0912757837.SGD","LU0320765992.SGD","TLT","LU0234570918.USD","LU1989772923.USD","LU0225283273.USD","US30Y.BOND","US7Y.BOND","US2Y.BOND","DECK","NBIX","LU0823416689.USD","LU0980610538.SGD","LU2357305700.SGD","CNC","LU2065171402.SGD","US12M.BOND","LU0795875169.SGD","LU1291159041.SGD","LU0158827781.USD","US5Y.BOND","TMF","LU0971096721.USD","LU2362540622.SGD","LU0648001328.SGD","US10Y.BOND","CNCG","LU1162221912.USD","LU0477156797.USD","LU1201861165.SGD","LU1732799900.SGD","US6M.BOND","LU0314104364.USD","LU0053666078.USD","BK4534","LU0557290698.USD","LU0154245673.USD","US3Y.BOND","BK4567","LU1064131342.USD","IE0002270589.USD","BMRN","TLTW","LU1244550577.SGD","LU0859254822.USD","VIG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639648182","title":"Capricor names Michael Maurer chief commercial officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2639648182","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639648182?lang=en_us&edition=fundamental","pubTime":"2026-05-29 09:58","pubTimestamp":1780019939,"startTime":"0","endTime":"0","summary":"Capricor Therapeutics appointed Michael Maurer as chief commercial officer, effective immediately, to strengthen launch readiness for Deramiocel in Duchenne muscular dystrophy.Maurer brings about two decades in rare-disease commercialization, patient access, and launch strategy, including work at Amicus Therapeutics, Sarepta Therapeutics, and Bristol Myers Squibb.At Sarepta, he led the U.S. launch of ELEVIDYS for Duchenne muscular dystrophy, shaping commercial strategy for the company’s approved RNA therapies.He will run the global commercial organization, covering market access, patient support, distribution strategy, and operational planning ahead of an Aug. 22, 2026 PDUFA date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capricor","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL68QMpR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","BK4581","LU2125154935.USD","LU1670710588.SGD","LU0306806265.USD","IE00BFTCPJ56.SGD","LU0306807586.USD","LU1670711123.USD","LU1868837300.USD","LU0456855351.SGD","LU1868836757.USD","LU0114720955.EUR","IE0002141913.USD","LU1323610961.USD","LU1989771016.USD","IE00BJT1NW94.SGD","BK4559","BK4139","LU0061475181.USD","BMRN","BK4585","IE00BFXG1179.USD","LU2133065610.SGD","LU2242652126.USD","LU0985481810.HKD","LU1718418525.SGD","BK4532","LU1883839398.USD","LU1261432733.SGD","BK4588","CAPR","LU1983299246.USD","LU1585245621.USD","LU0432979614.USD","LU0321505439.SGD","LU0237698245.USD","LU0267386448.USD","LU0321505868.SGD","LU1093756168.USD","LU1868836914.USD","LU2125154778.USD","BK4566","LU0882574055.USD","IE00B19Z3581.USD","IE00BJJMRZ35.SGD","LU0225771236.USD","IE00B19Z3B42.SGD","LU1571399168.USD","BMY","LU0096364046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638304478","title":"BioMarin Pharmaceutical (BMRN) Receives a Hold from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2638304478","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638304478?lang=en_us&edition=fundamental","pubTime":"2026-05-25 02:05","pubTimestamp":1779645918,"startTime":"0","endTime":"0","summary":"In a report released today, Paul Matteis from Stifel Nicolaus maintained a Hold rating on BioMarin Pharmaceutical, with a price target of $68.00. M...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/biomarin-pharmaceutical-bmrn-receives-a-hold-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/biomarin-pharmaceutical-bmrn-receives-a-hold-from-stifel-nicolaus-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","IE00B19Z3B42.SGD","BK4127","IE00B7SZLL34.SGD","BMRN","IE00B19Z3581.USD","SF","BK4139","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637371748","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2637371748","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637371748?lang=en_us&edition=fundamental","pubTime":"2026-05-24 08:51","pubTimestamp":1779583861,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on BioMarin Pharmaceutical (BMRN), Twist Bioscience (TW...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-183?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-183?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002270589.USD","IE00B19Z3B42.SGD","BK4139","TWST","BK4588","BK4585","IE00B19Z3581.USD","BK4566","BMRN","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637534969","title":"BioMarin Pharmaceutical Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2637534969","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637534969?lang=en_us&edition=fundamental","pubTime":"2026-05-23 02:14","pubTimestamp":1779473640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BMRN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 22, 2026 14:14 ET (18:14 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","IE0002270589.USD","BMRN","BK4139","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637315667","title":"BioMarin price target lowered to $111 from $116 at Canaccord","url":"https://stock-news.laohu8.com/highlight/detail?id=2637315667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637315667?lang=en_us&edition=fundamental","pubTime":"2026-05-22 18:40","pubTimestamp":1779446410,"startTime":"0","endTime":"0","summary":"Canaccord lowered the firm’s price target on BioMarin (BMRN) to $111 from $116 and keeps a Buy rating on the shares. The firm updated its model fol...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarin-price-target-lowered-to-111-from-116-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarin-price-target-lowered-to-111-from-116-at-canaccord-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4566","IE00B19Z3B42.SGD","IE0002270589.USD","BK4139","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BMRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637587683","title":"BioMarin's drug shows significant growth gains in children in late-stage trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637587683","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637587683?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:15","pubTimestamp":1779311746,"startTime":"0","endTime":"0","summary":"BioMarin's drug shows significant growth gains in children in late-stage trialMay 20  - BioMarin Pharmaceutical BMRN.O said on Wednesday its treatment for a rare condition that leads to short stature helped boost growth in children, meeting the main goal of a late-stage study and sending shares up nearly 5% in extended trading.Here are some details: The drug, Voxzogo, significantly increased the annualized growth rate in patients with hypochondroplasia after 52 weeks compared with placebo, with treated patients growing 2.33 cm more, the company said. Hypochondroplasia is a rare genetic skeletal disorder that affects bone growth and leads to short-limbed dwarfism.Patients receiving the therapy saw significant improvement in standing height and arm span, a key secondary goal of the study.The 80-patient study evaluated the drug in children aged 3 to 17 years. There are currently no approved treatments by the U.S. Food and Drug Administration or the European Medicines Agency for the disord","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nL4N41X1WP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4566","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BMRN","IE00B19Z3B42.SGD","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637136875","title":"BioMarin Says Phase 3 Study of Voxzogo Shows Patient Improvements","url":"https://stock-news.laohu8.com/highlight/detail?id=2637136875","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637136875?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:57","pubTimestamp":1779310620,"startTime":"0","endTime":"0","summary":"BioMarin Pharmaceutical said its phase 3 study of a treatment for a genetic disorder that causes dwarfism showed statistically significant improvements among participants.The trial evaluated BioMarin's Voxzogo drug among 80 children ages three to 17 with hypochondroplasia, a genetic skeletal disorder that causes short-limbed short stature.The study met its primary endpoint, demonstrating a statistically significant increase in annualized growth velocity compared with the placebo, BioMarin said. Children who received the drug also showed a statistically significant increase in standing height versus the placebo after a year of treatment as well as improvements in arm span.The company plans to submit its supplemental new drug application to the Food and Drug Administration in the third quarter, followed by submissions to the European Medicines Agency and other regional health authorities.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BioMarin Says Phase 3 Study of Voxzogo Shows Patient Improvements","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE0002270589.USD","IE00B7SZLL34.SGD","BMRN","IE00B19Z3581.USD","BK4566","IE00B19Z3B42.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637873749","title":"BioMarin’s Voxzogo meets endpoint in Phase 3 pediatric hypochondroplasia trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2637873749","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637873749?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:26","pubTimestamp":1779308765,"startTime":"0","endTime":"0","summary":"BioMarin (BMRN) Pharmaceutical announced that the Phase 3 CANOPY-HCH-3 study evaluating treatment with Voxzogo – vosoritide – in children with hypo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomarins-voxzogo-meets-endpoint-in-phase-3-pediatric-hypochondroplasia-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomarins-voxzogo-meets-endpoint-in-phase-3-pediatric-hypochondroplasia-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","IE00B19Z3581.USD","BK4566","IE00B19Z3B42.SGD","IE0002270589.USD","BMRN","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878015","title":"BioMarin plans FDA filing in Q3 2026 for Voxzogo in hypochondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878015?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:20","pubTimestamp":1779308424,"startTime":"0","endTime":"0","summary":"BioMarin plans to file a supplemental NDA with the FDA in Q3 2026 to expand VOXZOGO’s label to children with hypochondroplasia, following positive Phase 3 data.The CANOPY-HCH-3 trial met its primary endpoint, showing a 2.33 cm/year improvement in annualized growth velocity versus placebo at week 52.Submissions to the EMA and other regulators are expected to follow.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL5P0K77:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B7SZLL34.SGD","BMRN","BK4566","IE00B19Z3B42.SGD","IE0002270589.USD","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878063","title":"Biomarin Pharmaceutical Inc: Safety Findings Consistent With Established Profile in Achondroplasia","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878063","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878063?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:20","pubTimestamp":1779308400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA77XHNY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4566","IE00B19Z3581.USD","IE00B19Z3B42.SGD","IE0002270589.USD","BMRN","IE00B7SZLL34.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637878062","title":"Biomarin Pharmaceutical Inc - No New Safety Signals Identified in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2637878062","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637878062?lang=en_us&edition=fundamental","pubTime":"2026-05-21 04:20","pubTimestamp":1779308400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA77XHNY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","BK4139","IE0002270589.USD","BMRN","BK4566","IE00B19Z3581.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":178,"code":"91000000","status":"200"}]}}